2025-08-21 - Analysis Report
Okay, here's a report analyzing Natera Inc. (NTRA) based on the provided data.

**Natera Inc. (NTRA) Stock Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** NTRA
*   **Company Overview:** Natera Inc. is a genetic testing company focused on non-invasive prenatal testing (NIPT) and cancer screening.
*   **NTRA Cumulative Return:** -12.64%
*   **VOO (S&P 500) Cumulative Return:** 37.28%
*   **Absolute Divergence:** 49.92% (NTRA underperformed VOO by this amount)
*   **Relative Divergence:** 13.1 (Indicates NTRA's performance is in the lower range of its historical divergence from VOO.)
    * **Divergence Range:** max: 631.9, min: -39.3, 현재: 48.5, 상대이격도: 13.1

**Analysis:** NTRA has significantly underperformed the S&P 500 over the covered period. The relative divergence indicates that this underperformance is not unusual compared to its historical trading pattern against the index, suggesting specific company factors more than broad market trends are impacting the stock.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 0.0%   | 0.0%   | 0.0%   | 1.0  | 1.2    |
| 2016-2018  | 0.0%   | 0.0%   | 0.0%   | 1.0  | 1.9    |
| 2017-2019  | 0.0%   | 0.0%   | 0.0%   | 1.0  | 4.6    |
| 2018-2020  | 0.0%   | 0.0%   | 0.0%   | 1.0  | 13.7   |
| 2019-2021  | -17.0% | 0.0%   | -18.0% | 0.1  | 12.8   |
| 2020-2022  | -66.0% | 57.8%  | -56.0% | 0.1  | 5.5    |
| 2021-2023  | -51.0% | 69.3%  | -60.0% | 0.0  | 8.6    |
| 2022-2024  | 30.0%  | 70.1%  | 0.0%   | 0.0  | 21.7   |
| 2023-2025  | 51.0%  | 75.7%  | 8.0%   | -0.0 | 22.1   |

**Analysis:**
*   **Alpha:** The negative Alpha values in recent years (2019-2023) indicate that NTRA has underperformed its benchmark even after accounting for market risk.  The 2023-2025 period shows positive Alpha, suggesting recent outperformance.
*   **Beta:** Beta values close to 0 or negative suggest that NTRA's price movements have become less correlated or inversely correlated with the overall market in recent periods.  Historically, the Beta was closer to 1.
*   **CAGR:**  Highly volatile with significant negative returns in some periods.
*   **MDD:**  High Maximum Drawdown (MDD) values point to significant price declines from peak to trough, indicating high volatility and risk.

**2. Recent Stock Price Movements**

*   **Current Price:** 160.64
*   **Previous Close:** 160.12
*   **Change:** 0.32 (Slight increase)
*   **5-day Moving Average:** 160.674
*   **20-day Moving Average:** 147.4387
*   **60-day Moving Average:** 156.0011

**Analysis:** The current price is slightly above the previous close and very close to the 5-day moving average.  It's significantly above the 20-day and 60-day moving averages, suggesting a recent upward trend. The small price change from the previous close suggests no major price volatility due to news or trading.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3316 (Low Risk)
*   **RSI:** 82.92 (Overbought)
*   **PPO:** 1.68
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33) (Cash Ratio: 0% on 2025-08-11)
*   **Recent (20-day) Relative Divergence Change:** 0.6 (+) (Short-term Increase)
*   **Expected Return:** 110.6% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** Indicates the market conditions are currently considered low risk.
*   **RSI:** The RSI is high, indicating that the stock is overbought and may be due for a correction.
*   **PPO:** A positive PPO suggests the price is above its moving average, confirming the uptrend.
*   **Hybrid Signal:**  Recommends a Buy (80% of cash) based on the indicators.
*   **Recent Divergence Change:** Supports the recent upward price movement.
*   **Expected Return:** The very high expected return (over the S&P 500) suggests significant potential upside if held long-term (2+ years), but should be tempered by the stock's volatility and risk profile.

**4. Recent News & Significant Events**

*   **[2025-08-17]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-18]:** Analyst discussions on performance, industry trends, and global economic factors.
*   **[2025-08-19]:** Notable stock volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-21]:** Market experts highlight both risks and opportunities; advise monitoring news.

**Analysis:** The news indicates recent activity influencing NTRA, including volatility and events prompting analyst discussions. Investors should actively monitor news and announcements for further insights.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-08-08 | -0.74  | 0.55 B$    |
| 2025-05-09 | -0.5   | 0.50 B$    |
| 2024-11-12 | -0.26  | 0.44 B$    |
| 2024-08-09 | -0.3   | 0.41 B$    |
| 2025-08-08 | -0.3   | 0.41 B$    |

**Analysis:** While revenue has generally been increasing, the company continues to report negative earnings per share (EPS), although EPS has been improving. The most recent EPS is significantly negative.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $0.55B     | 63.41%        |
| 2025-03-31   | $0.50B     | 63.12%        |
| 2024-12-31   | $0.48B     | 62.94%        |
| 2024-09-30   | $0.44B     | 61.79%        |
| 2024-06-30   | $0.41B     | 58.83%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE        |
|--------------|------------|------------|
| 2025-06-30   | $1.25B     | -8.10%     |
| 2025-03-31   | $1.24B     | -5.40%     |
| 2024-12-31   | $1.20B     | -4.50%     |
| 2024-09-30   | $0.88B     | -3.60%     |
| 2024-06-30   | $0.84B     | -4.48%     |

**Analysis:** Revenue and Profit Margin are consistently growing, showing positive trends.
However, ROE is negative despite growing equity, indicating the company is not generating profits relative to its equity.

**7. Overall Summary and Conclusion**

Natera Inc. (NTRA) exhibits a mixed profile:

*   **Underperformance:** It has significantly underperformed the S&P 500 in the recent past, but there's a sign of recent reversal.
*   **Volatility:** High volatility and risk, as demonstrated by MDD, and the range of relative divergence.
*   **Recent Uptrend:** The stock is in a short-term uptrend, supported by moving averages and the recent relative divergence change.
*   **Technical Indicators:** RSI suggests it's overbought, while the Hybrid Signal recommends a Buy.
*   **Financials:** Revenue and profit margins are increasing, but EPS remains negative. ROE also remains negative despite equity growth.
*   **News:** Recent news suggests events are impacting the stock, requiring close monitoring.

**Conclusion:** NTRA presents a speculative investment opportunity. The high expected return is appealing, but investors should be aware of the stock's volatility, underperformance relative to the market, and ongoing unprofitability. Further investigation into the specific business developments, regulatory changes, and factors driving analyst discussions is crucial before making an investment decision. The recent uptrend may be a sign of a turnaround, but continued revenue growth and progress toward profitability are essential for sustained performance.
